Patent details

Basic Information

Publication number:

EP1315520

PCT Application Number:

PCT/EP/2001/010184

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019822410

PCT Publication Number:

WO/2002/020039

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

USE OF TRIFUNCTIONAL BISPECIFIC AND TRISPECIFIC ANTIBODIES FOR THE TREATMENT OF MALIGNANT ASCITES

French Title of Invention:

UTILISATION D'ANTICORPS TRIFONCTIONNELS BISPECIFIQUES ET TRISPECIFIQUES DANS LE TRAITEMENT D'ASCITES MALIGNES

German Title of Invention:

VERWENDUNG VON TRIFUNKTIONELLEN BISPEZIFISCHEN UND TRISPEZIFISCHEN ANTIKÖRPERN ZUR BEHANDLUNG VON MALIGNEM ASZITES

SPC Number:

91616

Dates

Filing date:

04/09/2001

Grant date:

04/05/2005

EP Publication Date:

04/05/2005

PCT Publication Date:

14/03/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/06/2003

EP B1 Publication Date:

04/05/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/09/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/12/2005

 

 

Name:

TRION PHARMA GMBH

Address:

Frankfurter Ring 193a, 80807 München, Germany (DE)

Agent

Name:

SPEICH STEPHANE

From:

24/06/2005

Address:

RUE DES BRUYERES 55, 1274, HOWALD, Luxembourg (LU)

To:

Inventor

Name:

Dr. Horst Lindhofer

Address:

Germany (DE)

Priority

Priority Number:

10043437

Priority Date:

04/09/2000

Priority Country:

Germany (DE)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

23/09/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

DENNEMEYER & CO